Special Issue "Bioactive Compounds from Marine Plankton"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 March 2013)

Special Issue Editor

Guest Editor
Prof. Dr. Georg Pohnert
Institute for Inorganic and Analytical Chemistry, Friedrich-Schiller-University Jena, Lessingstr. 8, D-07743 Jena, Germany
Website: http://www.uni-jena.de/Prof__Dr__Georg_Pohnert.html
E-Mail: georg.pohnert@uni-jena.de
Phone: +49 3641 948170
Fax: +49 3641 948172
Interests: marine chemical ecology; analytical chemistry; biosynthesis; oxylipins; lipids; terpenoids; phytoplankton

Special Issue Information

Dear Collegues,

The inhabitants of the open water are under the influence of gradual changes in nutrients, light, temperature, mechanical cues. But only chemical signals have the potential to provide important directional information about conspecific, predatory or competing species. Hence, a very interesting chemistry has developed that has the power to shape the ecosystem. But these interesting metabolic tasks also resulted in the evolution of metabolites with interesting pharmacological activity. Bioactive metabolites include for example dissolved gases, lipids, oxylipins, polyketides, peptides, and proteins that demonstrate a surprising structural and functional complexity. In this special issue we want to explore all topics in natural product chemistry of marine plankton and to illustrate current methodological and conceptual challenges in plankton research. Especially the complex interplay of toxins, nutrients and infochemicals shaping the marine plankton is of interest, but also the pharmacological activity, biosynthesis and genetics of the multitude of interesting metabolites will be covered in this special issue.
Recent progress reveals an emerging field that calls for special attention and I therefore invite you to contribute your exciting work to the special issue on “Marine Plankton” of Marine Drugs.

Prof. Dr. Georg Pohnert
Guest Editor

Submission

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Marine Drugs is an international peer-reviewed Open Access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs).

Keywords

  • marine plankton
  • phytoplankton
  • zooplankton
  • microbial loop
  • bioactive natural products
  • chemical ecology
  • chemical interactions
  • metabolites
  • lipids
  • oxylipins
  • red tides
  • polyketides
  • toxins

Published Papers (10 papers)

by , , , , , , ,  and
Mar. Drugs 2013, 11(1), 67-80; doi:10.3390/md11010067
Received: 22 September 2012; in revised form: 2 November 2012 / Accepted: 12 December 2012 / Published: 9 January 2013
Show/Hide Abstract | Cited by 6 | PDF Full-text (644 KB) | HTML Full-text | XML Full-text
abstract graphic

by , ,  and
Mar. Drugs 2013, 11(5), 1728-1762; doi:10.3390/md11051728
Received: 28 March 2013; in revised form: 24 April 2013 / Accepted: 25 April 2013 / Published: 22 May 2013
Show/Hide Abstract | Cited by 2 | PDF Full-text (2058 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , , ,  and
Mar. Drugs 2013, 11(7), 2259-2281; doi:10.3390/md11072259
Received: 16 April 2013; in revised form: 16 May 2013 / Accepted: 21 May 2013 / Published: 27 June 2013
Show/Hide Abstract | Cited by 7 | PDF Full-text (509 KB) | HTML Full-text | XML Full-text

by ,  and
Mar. Drugs 2013, 11(7), 2398-2412; doi:10.3390/md11072398
Received: 17 May 2013; in revised form: 19 June 2013 / Accepted: 28 June 2013 / Published: 11 July 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (401 KB) | HTML Full-text | XML Full-text

by  and
Mar. Drugs 2013, 11(7), 2459-2471; doi:10.3390/md11072459
Received: 9 April 2013; in revised form: 6 June 2013 / Accepted: 17 June 2013 / Published: 12 July 2013
Show/Hide Abstract | PDF Full-text (486 KB) | HTML Full-text | XML Full-text

by , ,  and
Mar. Drugs 2013, 11(7), 2486-2500; doi:10.3390/md11072486
Received: 11 April 2013; in revised form: 17 June 2013 / Accepted: 28 June 2013 / Published: 15 July 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (627 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

by , , , ,  and
Mar. Drugs 2013, 11(7), 2667-2681; doi:10.3390/md11072667
Received: 23 April 2013; in revised form: 7 June 2013 / Accepted: 8 July 2013 / Published: 23 July 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (657 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , , ,  and
Mar. Drugs 2013, 11(9), 3425-3471; doi:10.3390/md11093425
Received: 15 May 2013; in revised form: 2 July 2013 / Accepted: 24 July 2013 / Published: 9 September 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (613 KB) | HTML Full-text | XML Full-text
abstract graphic

by , ,  and
Mar. Drugs 2013, 11(11), 4158-4175; doi:10.3390/md11114158
Received: 12 August 2013; in revised form: 13 September 2013 / Accepted: 1 October 2013 / Published: 29 October 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (890 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , , , ,  and
Mar. Drugs 2013, 11(11), 4594-4611; doi:10.3390/md11114594
Received: 10 July 2013; in revised form: 6 September 2013 / Accepted: 9 October 2013 / Published: 14 November 2013
Show/Hide Abstract | PDF Full-text (892 KB) | HTML Full-text | XML Full-text

Last update: 10 October 2012

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert